SCHEMBL30719725

SCHEMBL30719725

Cc1ncccc1-c1cccnc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
CYP3A4 P08684 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
BLM P54132 1/20 0.53
AGER Q15109 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MYC P01106 2/20 0.51
MKNK1 Q9BUB5 1/20 0.50
MKNK2 Q9HBH9 1/20 0.50
CYP1A2 P05177 1/20 0.47
DHODH Q02127 1/20 0.45
NAPRT Q6XQN6 1/20 0.43
P2RX7 Q99572 1/20 0.42
PPARG P37231 1/20 0.42
TDO2 P48775 1/20 0.42
ASPH Q12797 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31265696 0.84 KDM4E (0.52) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL698990 0.84 KDM4E (0.52) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL14861469 0.82 KDM4E (0.50) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL3389125 0.81 KDM4E (0.49) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL27994859 0.80 KDM4E (0.52) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL3421959 0.79 MKNK1 (0.52) KDM4EMAPTCYP3A4ALOX15TSHR
SCHEMBL31469002 0.79 MKNK1 (0.52) KDM4EMAPTCYP3A4ALOX15TSHR
SCHEMBL2323790 0.79 KDM4E (0.50) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL7812554 0.79 L3MBTL1 (0.57) KDM4EALDH1A1MAPTCYP3A4ALOX15
SCHEMBL3390642 0.79 KDM4E (0.59) KDM4EALDH1A1MAPTCYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119343361-A Surface engineered extracellular vesicles and therapeutic uses thereof 转变生物公司 2025-01-21 CN disclosed
CN-114127059-B Macrocyclic chelators and methods of use thereof 詹森生物科技公司 2024-09-24 CN disclosed
CN-117396206-A Compounds for the treatment of NASH and NAFLD 吉利德科学公司 2024-01-12 CN disclosed